MedTech Industry Dynamics
MedTech Industry Dynamics
Olympus has announced the full commercial launch of the POWERSEAL Open Extended Jaw Sealer/Divider in the United States and Canada, a one-hand-operable surgical energy device indicated for sealing vessels up to 7mm in diameter across colorectal, gynecological, thoracic, urological, and vascular procedures.
Read MoreThe Government of Canada has announced funding of up to C$31.25 million toward Kardium’s C$125 million project to expand manufacturing capabilities for its Globe Pulsed Field System in Vancouver, British Columbia.
Read MoreMetriport has raised $26 million in new funding led by Matrix, with participation from ARTIS and Y Combinator, to expand its open-source data infrastructure platform that transforms fragmented patient records into structured, actionable information for clinicians at the point of care.
Read MorePhilips and Imricor have introduced a new Interventional MR lab solution combining Philips’ 1.5T MRI platform with Imricor’s MR-compatible systems and consumables, enabling an MR-guided workflow for cardiac intervention without compromising on MR field strength.
Read MorePhilips has received an up to $33.7 million award from ARPA-H to develop AI-enabled robotic procedure automation for stroke care, working with Johns Hopkins University and Boston University to expand access to specialized endovascular interventions.
Read MoreParadromics has received FDA approval to expand the types of computing devices that may be used with its investigational brain-computer interface (BCI) system in the Connect-One clinical study, enabling compatibility with personal laptops, tablets, and phones through its Convey user interface.
Read MoreAbbott has received FDA De Novo authorization for its Libre Duo 10 Day system, the world’s first dual glucose-ketone sensing technology designed to monitor glucose and detect rising ketone levels that can lead to diabetic ketoacidosis in people with diabetes.
Read MoreShape Memory Medical has closed a $10 million convertible note financing led by August Global Partners, with participation from Taiwania Capital, to support clinical development of its aortic portfolio including the AAA-SHAPE Pivotal Trial and FLAGSHIP feasibility study.
Read MoreRoche has received FDA clearance for its Elecsys pTau217 blood test, the first and only FDA-cleared single-biomarker test supporting both rule-in and rule-out assessment of amyloid pathology. Quest Diagnostics and Labcorp will offer the test to clinicians nationwide.
Read MoreSiemens Healthineers has been awarded up to $31.1 million by ARPA-H to advance autonomous remote endovascular robotics for acute ischemic stroke treatment, with the goal of enabling long-distance mechanical thrombectomy without direct human input.
Read More
